Pfizer Recalls Children’s Advil

Article

Pfizer Consumer Healthcare is recalling one lot of Children’s Advil Suspension Bubble Gum Flavored 4 FL OZ Bottle because of improperly marked dosage cups.

On Aug. 27, 2018, Pfizer Consumer Healthcare, a division of Pfizer Inc., announced it was voluntarily recalling one lot of Children’s Advil Suspension Bubble Gum Flavored 4 FL OZ Bottle. The recall was initiated after customers complained that the dosage cup provided is marked in teaspoons but the instructions on the label are described in milliliters (mL). The recalled product, NDC 0573-0207-30, lot R51129, was distributed nationwide from May–June 2018.

Children’s Advil Suspension Bubble Gum Flavored 4 FL OZ Bottle temporarily reduces fever and relieves minor aches and pains due to the common cold, flu, sore throat, headaches and toothaches. According to the company, the difference in measurements listed may potentially result in an overdose, which could cause nausea, vomiting, headache, drowsiness, blurred vision, and dizziness.

Source: FDA

 

Recent Videos
Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development
Industry Outlook 2025: The Rising Prominence of AI in Pharma